Finzati - Logo
MAIA logo

MAIA Biotechnology, Inc.

MAIA • Biotechnology
$1.12
▲ +0.05 (+4.67%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$83.91M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 1.66Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.12
Change4.67%
Market Cap$83.91M
52W Range0.87 - 3.19
Beta0.25
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio1.66
Quick Ratio1.66
Volume275.43K

Investment DNA

How strong this company looks for long-term investors

33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
66/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 1.66Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 7/28/2022
Industry: Biotechnology
P/B i: 20.68
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: 0.00
Current Ratio: 1.66
Quick Ratio: 1.66
Status: Good

Insider Transactions

Recent executive and insider activity

Smith Stan
Transaction: 06/30/2026
BUY
Change
+32,003
Price
$1.44
Filing
07/02/2026
Type
BUY
Luput Cristian
Transaction: 06/30/2026
BUY
Change
+27,610
Price
$1.44
Filing
07/02/2026
Type
BUY
Louie Ngar Yee
Transaction: 06/30/2026
BUY
Change
+32,630
Price
$1.44
Filing
07/02/2026
Type
BUY